J. Armstead, J. Morris, and D. Denning, Multi-Country Estimate of Different Manifestations of Aspergillosis in Cystic Fibrosis, PLoS ONE, vol.39, issue.6, p.98502, 2014.
DOI : 10.1371/journal.pone.0098502.s003

A. Warris, The biology of pulmonary aspergillus infections, Journal of Infection, vol.69, issue.1, pp.36-41, 2014.
DOI : 10.1016/j.jinf.2014.07.011

S. Park and B. Mehrad, Innate Immunity to Aspergillus Species, Clinical Microbiology Reviews, vol.22, issue.4, pp.535-551, 2009.
DOI : 10.1128/CMR.00014-09

A. Mccormick, J. Loeffler, and F. Ebel, Aspergillus fumigatus: contours of an opportunistic human pathogen, Cellular Microbiology, vol.51, issue.11, pp.1535-1543, 2010.
DOI : 10.1111/j.1462-5822.2010.01517.x

K. Schweer, C. Bangard, K. Hekmat, and O. Cornely, Chronic pulmonary aspergillosis, Mycoses, vol.46, issue.Suppl. 2, pp.257-270, 2014.
DOI : 10.1111/myc.12152

N. Smith and D. Denning, Underlying conditions in chronic pulmonary aspergillosis including simple aspergilloma, European Respiratory Journal, vol.37, issue.4, pp.865-872, 2011.
DOI : 10.1183/09031936.00054810

D. Denning, K. Riniotis, R. Dobrashian, and H. Sambatakou, Chronic Cavitary and Fibrosing Pulmonary and Pleural Aspergillosis: Case Series, Proposed Nomenclature Change, and Review, Clinical Infectious Diseases, vol.37, issue.s3, pp.265-280, 2003.
DOI : 10.1086/376526

J. Cadranel, G. Ferretti, H. Pelloux, and C. Pison, Grenoble Aspergillus Committee. 2015. 334 Characteristics and outcomes of chronic pulmonary aspergillosis: a retrospective 335 analysis of a tertiary hospital registry, Clin Respir J, vol.9, pp.65-73

E. Bouza, Pulmonary aspergillosis in patients with chronic obstructive pulmonary 338 disease: incidence, risk factors, and outcome, Clin Microbiol Infect, vol.16, pp.870-877, 2010.

D. Denning, A. Pleuvry, and D. Cole, Global burden of allergic bronchopulmonary 340 aspergillosis with asthma and its complication chronic pulmonary aspergillosis in adults, 2013.

D. Denning, ABPA complicating asthma ISHAM working group Allergic 347 bronchopulmonary aspergillosis: review of literature and proposal of new diagnostic and 348 classification criteria, Clin Exp Allergy, vol.43, pp.850-873, 2013.

I. Page, M. Richardson, and D. Denning, Antibody testing in aspergillosis--quo vadis?, Medical Mycology, vol.53, issue.5, pp.417-439, 2015.
DOI : 10.1093/mmy/myv020

V. Kurup and A. Kumar, Immunodiagnosis of aspergillosis., Clinical Microbiology Reviews, vol.4, issue.4, pp.439-456, 1991.
DOI : 10.1128/CMR.4.4.439

F. Persat, [Aspergillus serology, from yesterday to today for tomorrow], J Mycol, vol.354, issue.22, pp.72-82, 2012.

J. Guitard, B. Sendid, S. Thorez, M. Gits, and C. Hennequin, Evaluation of a Recombinant Antigen-Based Enzyme Immunoassay for the Diagnosis of Noninvasive Aspergillosis, Journal of Clinical Microbiology, vol.50, issue.3, pp.762-765, 2012.
DOI : 10.1128/JCM.01257-11

C. Pinel, Recombinant allergens combined with biological markers in the 363 diagnosis of allergic bronchopulmonary aspergillosis in cystic fibrosis patients, Clin, vol.364, 2010.

C. Godet, P. B. Laurent, F. Cadranel, and J. , Chronic Pulmonary Aspergillosis: An Update on Diagnosis and Treatment, Respiration, vol.88, issue.2, pp.162-174, 2014.
DOI : 10.1159/000362674

R. Moss, Allergic bronchopulmonary aspergillosis and Aspergillus infection in cystic fibrosis, Current Opinion in Pulmonary Medicine, vol.16, issue.6, pp.598-603, 2010.
DOI : 10.1097/MCP.0b013e32833e24a6

A. Glas, J. Lijmer, M. Prins, G. Bonsel, and P. Bossuyt, The diagnostic odds ratio: a single indicator of test performance, Journal of Clinical Epidemiology, vol.56, issue.11, pp.1129-1135, 2003.
DOI : 10.1016/S0895-4356(03)00177-X

J. Vergnon, P. Gay, C. A. Piarroux, R. Pelloux, H. Ranque et al., Evaluation of 388 the Aspergillus Western blot IgG kit for diagnosis of chronic aspergillosis, J Clin, p.389, 2015.

M. Bordier-bio-rad, I. Bordier, /. Bio-rad-bordier, /. Ipd-bio-rad, /. Ipd-se et al., All sera n=220 97

%. Sp and . Ci, All sera n=59 71

. Se, Sensitivity Sp: specificity 421 * Cochran Q test 422 ? Equivocal results were considered positive 423 ¥ McNemar post-hoc tests showed no significant difference 424 ? Youden's index = sensitivity, p.1